Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope 2024-01-18 16:00
Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Asia Pacific 2024-01-18 12:00
FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US 2024-01-18 10:31
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC) 2024-01-17 20:00
WuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBody™ 2024-01-17 08:30
Complete Genomics and Gencove Announce agreement at Plant and Animal Genome Conference (PAG 31) to offer a bundled solution for low-pass whole genome sequencing 2024-01-16 22:00
FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY 2024-01-16 21:00
Chipscreen NewWay: First Patient Dosed in Phase 1 Trial of the Bispecific Antibody NWY001, a Next-generation Tumor Immunotherapy in Patients with Advanced Solid Tumors 2024-01-16 17:00
CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer 2024-01-16 15:00
CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection 2024-01-15 21:50
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India 2024-01-15 12:00
Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia 2024-01-15 08:08
San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry 2024-01-12 23:28
Subject Enrollment Completed for International Multicenter Comparative Clinical (Phase 3) Study of Boan Biotech's Denosumab 2024-01-12 21:15
Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule 2024-01-12 20:30
RemeGen's RC88 Obtained FDA Fast Track Designation, Heralds New Hope for Ovarian Cancer Patients 2024-01-12 18:17
ClinChoice Acquires CSI, Expanding its Global Footprint into Southeast Asia 2024-01-12 11:00
GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia 2024-01-11 19:00
CEO of Kelun-Biotech Dr. Micheal Ge delivered a presentation on The 42nd JPM Annual Healthcare Conference 2024-01-11 17:55
CEO of Kelun-Biotech Dr. Micheal Ge delivered a presentation on The 42nd JPM Annual Healthcare Conference 2024-01-11 16:32
1 57 58 59 60 61 451